1,347
Views
14
CrossRef citations to date
0
Altmetric
Review Articles

Pseudomonas aeruginosa and Staphylococcus aureus communication in biofilm infections: insights through network and database construction

ORCID Icon, ORCID Icon & ORCID Icon
Pages 712-728 | Received 02 May 2019, Accepted 29 Nov 2019, Published online: 13 Dec 2019

References

  • Allen RC, Popat R, Diggle SP, Brown SP. 2014. Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol. 12(4):300–308.
  • Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, Kjelleberg S, Molin S, Givskov M, Tolker-Nielsen T. 2006. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol. 59(4):1114–1128.
  • Alves PM, Al-Badi E, Withycombe C, Jones PM, Purdy KJ, Maddocks SE. 2018. Interaction between Staphylococcus aureus and Pseudomonas aeruginosa is beneficial for colonisation and pathogenicity in a mixed biofilm. Pathog Dis. 76:fty003.
  • Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. 2011. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence. 2(5):445–459.
  • Armbruster CR, Wolter DJ, Mishra M, Hayden HS, Radey MC, Merrihew G, MacCoss MJ, Burns J, Wozniak DJ, Parsek MR, et al. 2016. Staphylococcus aureus protein a mediates interspecies interactions at the cell surface of Pseudomonas aeruginosa. MBio. 7(3):e00538–16.
  • Arya R, Princy SA. 2016. Exploration of modulated genetic circuits governing virulence determinants in Staphylococcus aureus. Indian J Microbiol. 56(1):19–27.
  • Balasubramanian D, Schneper L, Kumari H, Mathee K. 2013. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 41(1):1–20.
  • Bhattacharya M, Wozniak DJ, Stoodley P, Hall-Stoodley L. 2015. Prevention and treatment of Staphylococcus aureus biofilms. Expert Rev anti Infect Ther. 13(12):1499–1516.
  • Biswas L, Biswas R, Schlag M, Bertram R, Götz F. 2009. Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl Environ Microbiol. 75(21):6910–6912.
  • Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 48(1):1–12.
  • Brackman G, Garcia-Fernandez MJ, Lenoir J, De Meyer L, Remon JP, De Beer T, Concheiro A, Alvarez-Lorenzo C, Coenye T. 2016. Dressings loaded with cyclodextrin–hamamelitannin complexes increase Staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communities. Macromol Biosci. 16(6):859–869.
  • Brandel J, Humbert N, Elhabiri M, Schalk IJ, Mislin GLA, Albrecht-Gary A-M. 2012. Pyochelin, a siderophore of Pseudomonas aeruginosa: Physicochemical characterization of the iron(iii), copper(ii) and zinc(ii) complexes. Dalton Trans. 41(9):2820.
  • Bredenbruch F, Geffers R, Nimtz M, Buer J, Haussler S. 2006. The Pseudomonas aeruginosa quinolone signal (PQS) has an iron-chelating activity. Environ Microbiol. 8(8):1318–1329.
  • Breidenstein EBM, de la Fuente-Núñez C, Hancock R. 2011. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19(8):419–426.
  • Brown S, Cornforth D, Mideo N. 2012. Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends Microbiol. 20(7):336–342.
  • Carty NL, Layland N, Colmer-Hamood JA, Calfee MW, Pesci EC, Hamood AN. 2006. PtxR modulates the expression of QS-controlled virulence factors in the Pseudomonas aeruginosa strain PAO1. Mol Microbiol. 61(3):782–794.
  • Castillo-Juárez I, Maeda T, Mandujano-Tinoco EA, Tomás M, Pérez-Eretza B, García-Contreras SJ, Wood TK, García-Contreras R. 2015. Role of quorum sensing in bacterial infections. WJCC. 3(7):575–598.
  • Chan KG, Liu YC, Chang CY. 2015. Inhibiting N-acyl-homoserine lactone synthesis and quenching Pseudomonas quinolone quorum sensing to attenuate virulence. Front Microbiol. 6:1173.
  • Cheung GYC, Joo H-S, Chatterjee SS, Otto M. 2014. Phenol-soluble modulins – critical determinants of staphylococcal virulence. FEMS Microbiol Rev. 38(4):698–719.
  • Cheung GYC, Wang R, Khan BA, Sturdevant DE, Otto M. 2011. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun. 79(5):1927–1935.
  • Chopra I, Schofield C, Everett M, O'Neill A, Miller K, Wilcox M, Frère J-M, Dawson M, Czaplewski L, Urleb U, et al. 2008. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis. 8(2):133–139.
  • Ciofu O, Tolker-Nielsen T, Jensen PØ, Wang H, Høiby N. 2015. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv Drug Deliv Rev. 85:7–23.
  • Ciulla M, Di Stefano A, Marinelli L, Cacciatore I, Di Biase G. 2019. RNAIII inhibiting peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections. CTMC. 18(24):2068–2079.
  • Costerton JW. 2001. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol. 9(2):50–52.
  • Davey M. E, Caiazza N. C, O'Toole G. A. 2003. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol. 185(3):1027–1036.
  • DeLeon S, Clinton A, Fowler H, Everett J, Horswill AR, Rumbaugh KP. 2014. Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect Immun. 82(11):4718–4728.
  • Dickey SW, Cheung GYC, Otto M. 2017. Different drugs for bad bugs: Antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 16(7):457–471.
  • Diggle SP, Matthijs S, Wright VJ, Fletcher MP, Chhabra SR, Lamont IL, Kong X, Hider RC, Cornelis P, Cámara M, et al. 2007. The Pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum sensing and iron entrapment. Chem Biol. 14(1):87–96.
  • Dixon EF, Hall RA. 2015. Noisy neighbourhoods: quorum sensing in fungal-polymicrobial infections. Cell Microbiol. 17(10):1431–1441.
  • Dubern J-F, Diggle SP. 2008. Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. Mol Biosyst. 4(9):882–888.
  • Fetzner S. 2015. Quorum quenching enzymes. J Biotechnol. 201:2–14.
  • Fey PD. 2010. Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr Opin Microbiol. 13(5):610–615.
  • Filkins L M, Graber J A, Olson D G, Dolben E L, Lynd L R, Bhuju S, O'Toole G A. 2015. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa drives S. aureus towards fermentative metabolism and reduced viability in a cystic fibrosis model. J Bacteriol. 197(14):2252–2264.
  • Fisher EL, Otto M, Cheung G. 2018. Basis of virulence in enterotoxin-mediated staphylococcal food poisoning. Front Microbiol. 9:436.
  • Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Hoiby N, Molin SS, Høiby N, Molin SS. 2012. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: An evolutionary perspective. Nat Rev Microbiol. 10(12):841–851.
  • Foster TJ, Geoghegan JA, Ganesh VK, Höök M. 2014. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 12(1):49–62.
  • Frimmersdorf E, Horatzek S, Pelnikevich A, Wiehlmann L, Schomburg D. 2010. How Pseudomonas aeruginosa adapts to various environments: a metabolomic approach. Environ Microbiol. 12(6):1734–1747.
  • Fugère A, Séguin DL, Mitchell G, Déziel E, Dekimpe V, Cantin AM, Frost E, Malouin F. 2014. Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients. PLoS One. 9(1):e86705.
  • Garcia LG, Lemaire S, Kahl BC, Becker K, Proctor RA, Denis O, Tulkens PM, Van Bambeke F. 2013. Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J Antimicrob Chemother. 68(7):1455–1464.
  • García-Contreras R, Peréz-Eretza B, Jasso-Chávez R, Lira-Silva E, Roldán-Sánchez J A, González-Valdez A, Soberón-Chávez G, Coria-Jiménez R, Martínez-Vázquez M, Alcaraz L D, et al. 2015. High variability in quorum quenching and growth inhibition by furanone C-30 in Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients. Pathog Dis. 73(6):ftv040.
  • Goerke C, Campana S, Bayer MG, Döring G, Botzenhart K, Wolz C. 2000. Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro. Infect Immun. 68(3):1304–1311.
  • Grandclément C, Tannières M, Moréra S, Dessaux Y, Faure D. 2016. Quorum quenching: role in nature and applied developments. FEMS Microbiol Rev. 40(1):86–116.
  • Hall S, McDermott C, Anoopkumar-Dukie S, McFarland A, Forbes A, Perkins A, Davey A, Chess-Williams R, Kiefel M, Arora D, et al. 2016. Cellular effects of pyocyanin, a secreted virulence factor of Pseudomonas aeruginosa. Toxins. 8(8):236.
  • Hammond JH, Dolben EF, Smith TJ, Bhuju S, Hogan DA. 2015. Links between Anr and quorum sensing in Pseudomonas aeruginosa biofilms. J Bacteriol. 197(17):2810–2820.
  • Hauser AR. 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol. 7(9):654–665.
  • Hawver LA, Jung SA, Ng WL. 2016. Specificity and complexity in bacterial quorum-sensing systems. FEMS Microbiol Rev. 40(5):738–752.
  • Hoffman L. R, Deziel E, D'Argenio D. A, Lepine F, Emerson J, McNamara S, Gibson R. L, Ramsey B. W, Miller S. I. 2006. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 103(52):19890–19895.
  • Høiby N. 2011. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med. 9(1):32.
  • Jakobsen TH, Bjarnsholt T, Jensen PØ, Givskov M, Høiby N. 2013. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors. Future Microbiol. 8(7):901–921.
  • Jennings MT, Dasenbrook EC, Lechtzin N, Boyle MP, Merlo CA. 2017. Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. J Cyst Fibros. 16(6):681–686.
  • Jorge P, Lourenço A, Pereira MO. 2012. New trends in peptide-based anti-biofilm strategies: a review of recent achievements and bioinformatic approaches. Biofouling. 28(10):1033–1061.
  • Jorge P, Magalhães AP, Grainha T, Alves D, Sousa AM, Lopes SP, Pereira MO. 2019. Antimicrobial resistance three ways: healthcare crisis, major concepts and the relevance of biofilms. FEMS Microbiol Ecol. 95.
  • Kazmierczak BI, Schniederberend M, Jain R. 2015. Cross-regulation of Pseudomonas motility systems: the intimate relationship between flagella, pili and virulence. Curr Opin Microbiol. 28:78–82.
  • Knecht L D, O'Connor G, Mittal R, Liu X Z, Daftarian P, Deo S K, Daunert S. 2016. Serotonin activates bacterial quorum sensing and enhances the virulence of Pseudomonas aeruginosa in the host. EBioMedicine. 9:161–169.
  • Kong C, Neoh H, Nathan S. 2016. Targeting Staphylococcus aureus toxins: A potential form of anti-virulence therapy. Toxins. 8(3):72.
  • Le KY, Otto M. 2015. Quorum-sensing regulation in staphylococci-an overview. Front Microbiol. 6:1174.
  • Lee J, Wu J, Deng Y, Wang J, Wang C, Wang J, Chang C, Dong Y, Williams P, Zhang LH. 2013. A cell-cell communication signal integrates quorum sensing and stress response. Nat Chem Biol. 9(5):339–343.
  • Lee J, Zhang L. 2015. The hierarchy quorum sensing network in Pseudomonas aeruginosa. Protein Cell. 6(1):26–41.
  • Lequette Y, Greenberg EP. 2005. Timing and localization of rhamnolipid synthesis gene expression in Pseudomonas aeruginosa biofilms. J Bacteriol. 187(1):37–44.
  • Lister JL, Horswill AR. 2014. Staphylococcus aureus biofilms: Recent developments in biofilm dispersal. Front Cell Infect Microbiol. 4:178.
  • Liu Q, Yeo W, Bae T. 2016. The SaeRS two‐component system of Staphylococcus aureus. Genes. 7(10):81.
  • Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 15(2):194–222.
  • Martínez OF, Cardoso MH, Ribeiro SM, Franco OL. 2019. Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition. Front Cell Infect Microbiol. 9:74.
  • Mashburn LM, Jett AM, Akins DR, Whiteley M. 2005. Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J Bacteriol. 187(2):554–566.
  • Maura D, Hazan R, Kitao T, Ballok AE, Rahme LG. 2016. Evidence for direct control of virulence and defense gene circuits by the Pseudomonas aeruginosa quorum sensing regulator, MvfR. Sci Rep. 6(1):1–14.
  • Michalska M, Wolf P. 2015. Pseudomonas exotoxin A: Optimized by evolution for effective killing. Front Microbiol. 6:963.
  • Miller CL, Van Laar TA, Chen T, Karna SLR, Chen P, You T, Leung KP. 2017. Global transcriptome responses including small RNAs during mixed-species interactions with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Microbiol Open. 6:e00427.
  • Mitchell G, Séguin DL, Asselin A-E, Déziel E, Cantin AM, Frost EH, Michaud S, Malouin F. 2010. Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide. BMC Microbiol. 10(1):33.
  • Mulcahy LR, Isabella VM, Lewis K. 2014. Pseudomonas aeruginosa biofilms in disease. Microb Ecol. 68(1):1–12.
  • Nair N, Biswas R, Götz F, Biswas L. 2014. Impact of Staphylococcus aureus on pathogenesis in polymicrobial infections. Infect Immun. 82(6):2162–2169.
  • Nguyen AT, Oglesby-Sherrouse AG. 2015. Spoils of war: iron at the crux of clinical and ecological fitness of Pseudomonas aeruginosa. Biometals. 28(3):433–443.
  • Ochsner UA, Wilderman PJ, Vasil AI, Vasil ML. 2002. GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes. Mol Microbiol. 45(5):1277–1287.
  • Orazi G, O’Toole GA. 2017. Pseudomonas aeruginosa alters Staphylococcus aureus sensitivity to vancomycin in a biofilm model of cystic fibrosis infection. MBio. 8(4):e00873–17.
  • Otto M. 2014. Staphylococcus aureus toxins. Curr Opin Microbiol. 17:32–37.
  • Pader V, James EH, Painter KL, Wigneshweraraj S, Edwards AM. 2014. The Agr quorum-sensing system regulates fibronectin binding but not hemolysis in the absence of a functional electron transport chain. Infect Immun. 82(10):4337–4347.
  • Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol. 187(15):5267–5277.
  • Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. 2019. Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnol Adv. 37(1):177–192.
  • Pérez-Pérez M, Jorge P, Pérez Rodríguez G, Pereira MO, Lourenço A. 2017. Quorum sensing inhibition in Pseudomonas aeruginosa biofilms: new insights through network mining. Biofouling. 33(2):128–142.
  • Pesci EC, Pearson JP, Seed PC, Iglewski BH. 1997. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol. 179(10):3127–3132.
  • Pietrocola G, Nobile G, Rindi S, Speziale P. 2017. Staphylococcus aureus manipulates innate immunity through own and host-expressed proteases. Front Cell Infect Microbiol. 7:166.
  • Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG, Sogin ML, O’Toole GA. 2013. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome. 1(1):27.
  • Proctor RA, Kriegeskorte A, Kahl BC, Becker K, Löffler B, Peters G. 2014. Staphylococcus aureus small colony variants (SCVs): A road map for the metabolic pathways involved in persistent infections. Front Cell Infect Microbiol. 4:99.
  • Radlinski L, Rowe SE, Kartchner LB, Maile R, Cairns BA, Vitko NP, Gode CJ, Lachiewicz AM, Wolfgang MC, Conlon BP. 2017. Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus. PLoS Biol. 15(11):e2003981.
  • Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L. 2009. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest. 136(6):1554–1560.
  • Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick R. P. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet. 202(1):58–61.
  • Reinhart AA, Oglesby-Sherrouse AG. 2016. Regulation of Pseudomonas aeruginosa virulence by distinct iron sources. Genes. 7(12):126.
  • Rodrigo-Troyano A, Sibila O. 2017. The respiratory threat posed by multidrug resistant Gram-negative bacteria. Respirology. 22(7):1288–1299.
  • Rogers GB, Hoffman LR, Whiteley M, Daniels T V, Carroll MP, Bruce KD. 2010. Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends Microbiol. 18(8):357–364.
  • Sayers EW, Beck J, Brister JR, Bolton EE, Canese K, Comeau DC, Funk K, Ketter A, Kim S, Kimchi A. 2019. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 47(D1):D23–D28.
  • Schmidtchen A, Wolff H, Hansson C. 2001. Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers. Acta Derm Venereol. 81(6):406–409.
  • Scoffone VC, Trespidi G, Chiarelli LR, Barbieri G, Buroni S. 2019. Quorum sensing as antivirulence target in cystic fibrosis pathogens. Int J Mol Sci. 20:pii: E1838.
  • Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11):2498–2504.
  • Sharma G, Rao S, Bansal A, Dang S, Gupta S, Gabrani R. 2014. Pseudomonas aeruginosa biofilm: potential therapeutic targets. Biologicals. 42(1):1–7.
  • Shen K, Sayeed S, Antalis P, Gladitz J, Ahmed A, Dice B, Janto B, Dopico R, Keefe R, Hayes J, et al. 2006. Extensive genomic plasticity in Pseudomonas aeruginosa revealed by identification and distribution studies of novel genes among clinical isolates. Infect Immun. 74(9):5272–5283.
  • Shrout JD, Chopp DL, Just CL, Hentzer M, Givskov M, Parsek MR. 2006. The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Mol Microbiol. 62(5):1264–1277.
  • Silby MW, Winstanley C, Godfrey SAC, Levy SB, Jackson RW. 2011. Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev. 35(4):652–680.
  • Sobin L, Kawai K, Irace AL, Gergin O, Cunningham M, Sawicki GS, Adil EA. 2017. Microbiology of the upper and lower airways in pediatric cystic fibrosis patients. Otolaryngol Head Neck Surg. 157(2):302–308.
  • Solano C, Echeverz M, Lasa I. 2014. Biofilm dispersion and quorum sensing. Curr Opin Microbiol. 18:96–104.
  • Stacy A, McNally L, Darch SE, Brown SP, Whiteley M. 2016. The biogeography of polymicrobial infection. Nat Rev Microbiol. 14(2):93–105.
  • Tognon M, Köhler T, Luscher A, Van Delden C. 2019. Transcriptional profiling of Pseudomonas aeruginosa and Staphylococcus aureus during in vitro co-culture. BMC Genomics. 20(1):30.
  • Totsika M. 2016. Benefits and challenges of antivirulence antimicrobials at the dawn of the post-antibiotic era. DDL. 6(1):30–37.
  • Troxell B, Hassan HM. 2013. Transcriptional regulation by ferric uptake regulator (Fur) in pathogenic bacteria. Front Cell Infect Microbiol. 3:59.
  • Tuchscherr L, Heitmann V, Hussain M, Viemann D, Roth J, von Eiff C, Peters G, Becker K, Löffler B. 2010. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis. 202(7):1031–1040.
  • Tuchscherr L, Medina E, Hussain M, Völker W, Heitmann V, Niemann S, Holzinger D, Roth J, Proctor R A, Becker K, et al. 2011. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med. 3(3):129–141.
  • Turner KH, Everett J, Trivedi U, Rumbaugh KP, Whiteley M. 2014. Requirements for Pseudomonas aeruginosa acute burn and chronic surgical wound infection. PLoS Genet. 10(7):e1004518.
  • Ueda A, Wood TK. 2009. Connecting quorum sensing, c-di-GMP, pel polysaccharide, and biofilm formation in Pseudomonas aeruginosa through tyrosine phosphatase TpbA (PA3885). PLoS Pathog. 5(6):e1000483.
  • Venkatesan N, Perumal G, Doble M. 2015. Bacterial resistance in biofilm-associated bacteria. Future Microbiol. 10(11):1743–1750.
  • Vuong C, Kocianova S, Yao Y, Carmody AB, Otto M. 2004. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis. 190(8):1498–1505.
  • Vuong C, Saenz HL, Götz F, Otto M. 2000. Impact of the agr quorum‐sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis. 182(6):1688–1693.
  • Waters CM, Bassler BL. 2005. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol. 21(1):319–346.
  • Watkins RR, Holubar M, David MZ. 2019. Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother. 63(12).
  • Wendlandt S, Schwarz S, Silley P. 2013. Methicillin-resistant Staphylococcus aureus: A food-borne pathogen? Annu Rev Food Sci Technol. 4(1):117–139.
  • Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. 2002. Extracellular DNA required for bacterial biofilm formation. Science. 295(5559):1487.
  • WHO 2017a. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities; [accessed 2019 Dec 5]. https://www.who.int/infection-prevention/publications/guidelines-cre/en/.
  • WHO 2017b. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; [accessed 2019 Dec 05]. https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/.
  • Williams P, Cámara M. 2009. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol. 12(2):182–191.
  • Woods PW, Haynes ZM, Mina EG, Marques C. 2018. Maintenance of S. aureus in co-culture with P. aeruginosa while growing as biofilms. Front Microbiol. 9:3291.
  • Zielinska AK, Beenken KE, Mrak LN, Spencer HJ, Post GR, Skinner RA, Tackett AJ, Horswill AR, Smeltzer MS. 2012. SarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates. Mol Microbiol. 86(5):1183–1196.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.